Spironolactone: Disposition, Metabolism, Pharmacodynamics, and Bioavailability
- 1 January 1978
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 8 (1) , 151-188
- https://doi.org/10.3109/03602537808993782
Abstract
(1978). Spironolactone: Disposition, Metabolism, Pharmacodynamics, and Bioavailability. Drug Metabolism Reviews: Vol. 8, No. 1, pp. 151-188.Keywords
This publication has 56 references indexed in Scilit:
- Metabolism of digitoxin in man and its modification by spironolactoneEuropean Journal of Clinical Pharmacology, 1976
- Investigation of the effects of methyltestosterone, cortisone and spironolactone on the hepatic microsomal mixed function oxidase system in male and female ratsBiochemical Pharmacology, 1973
- The Effect of Spironolactone on Antipyrine Metabolism in ManPharmacology, 1973
- Spironolactone—a weak enzyme inducer in manJournal of Pharmacy and Pharmacology, 1972
- Metabolism of Aniline and Hexobarbital by Liver Homogenates of Spironolactone-Pretreated Male RatsJournal of Pharmaceutical Sciences, 1972
- Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systemsBiochemical Pharmacology, 1971
- Stimulation of Liver Microsomal Drug Metabolism in Male and Female Mice by Spironolactone and AldadieneExperimental Biology and Medicine, 1971
- The influence of spironolactone on its own-biotransformationSteroids, 1970
- Prevention of Digitoxin Poisoning by Various SteroidsJournal of Pharmaceutical Sciences, 1969
- Digitoxin Poisoning: Prevention by SpironolactoneScience, 1969